Sign Out
To improve glycemic control in patients with non-insulin dependent diabetes mellitus (NIDDM) where there is poor diet control; primary and secondary failures to sulfonylurea treatment and those having a trend for increasing the body weight; diabetic with an exceeding body weight.
Humamet can be given alone as an initial treatment or to supplement treatment with a sulfonylurea. In patients with insulin-dependent diabetes mellitus (type I) who are not adequately controlled, Humamet can be added to their existing treatment regimen.
